Oncology

A quantum-assisted model classified lung cancer records with 91.90% accuracy, but clinical validation remains essential.

A multimodal AI model combining skin images and clinical metadata achieved improved classification performance across three datasets, highlighting its potential for dermatological decision support.

Risvutatug rezetecan ADC treatment extended progression-free survival in relapsed osteosarcoma, but serious toxicity was frequent.

A review links ovarian colorectal metastases to lower chemotherapy response and examines the role of surgery.

Ivonescimab plus chemotherapy improved survival compared with current standard treatment durvalumab plus chemotherapy in advanced biliary tract cancer.

Adding darolutamide to hormone therapy and radiotherapy improved metastasis-free survival in high-risk prostate cancer, according to research presented at ESMO 2026.

EndoRare generated synthetic gastrointestinal lesion images from one reference, improving AI classifier performance and supporting novice recognition.

Osimertinib plus savolitinib cut death risk by 32% versus chemotherapy in selected patients with resistant lung cancer, according to new trial results presented at ESMO 2026.